Candel Therapeutics Statistics
Total Valuation
CADL has a market cap or net worth of $342.06 million. The enterprise value is $337.17 million.
Market Cap | 342.06M |
Enterprise Value | 337.17M |
Important Dates
The last earnings date was Tuesday, May 14, 2024, before market open.
Earnings Date | May 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CADL has 29.74 million shares outstanding. The number of shares has increased by 0.96% in one year.
Shares Outstanding | 29.74M |
Shares Change (YoY) | +0.96% |
Shares Change (QoQ) | +0.74% |
Owned by Insiders (%) | 33.19% |
Owned by Institutions (%) | 15.10% |
Float | 18.22M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 57.21 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 3.53.
Current Ratio | 2.01 |
Quick Ratio | n/a |
Debt / Equity | 3.53 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -13.20 |
Financial Efficiency
Return on equity (ROE) is -206.10% and return on invested capital (ROIC) is -135.46%.
Return on Equity (ROE) | -206.10% |
Return on Assets (ROA) | -82.50% |
Return on Capital (ROIC) | -135.46% |
Revenue Per Employee | n/a |
Profits Per Employee | -$889,643 |
Employee Count | 42 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +637.18% in the last 52 weeks. The beta is -0.93, so CADL's price volatility has been lower than the market average.
Beta (1Y) | -0.93 |
52-Week Price Change | +637.18% |
50-Day Moving Average | 5.53 |
200-Day Moving Average | 2.26 |
Relative Strength Index (RSI) | 64.16 |
Average Volume (30 Days) | 5,569,462 |
Short Selling Information
The latest short interest is 1.05 million, so 3.55% of the outstanding shares have been sold short.
Short Interest | 1.05M |
Short Previous Month | 2.03M |
Short % of Shares Out | 3.55% |
Short % of Float | 5.79% |
Short Ratio (days to cover) | 0.07 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -36.66M |
Pretax Income | -37.37M |
Net Income | -37.37M |
EBITDA | -33.50M |
EBIT | -34.73M |
Earnings Per Share (EPS) | -$1.28 |
Balance Sheet
The company has $25.98 million in cash and $21.09 million in debt, giving a net cash position of $4.89 million or $0.16 per share.
Cash & Cash Equivalents | 25.98M |
Total Debt | 21.09M |
Net Cash | 4.89M |
Net Cash Per Share | $0.16 |
Equity / Book Value | 5.98M |
Book Value Per Share | 0.20 |
Working Capital | 13.60M |
Cash Flow
In the last 12 months, operating cash flow was -$31.86 million and capital expenditures -$306,000, giving a free cash flow of -$32.17 million.
Operating Cash Flow | -31.86M |
Capital Expenditures | -306,000 |
Free Cash Flow | -32.17M |
FCF Per Share | -$1.10 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CADL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.96% |
Shareholder Yield | -0.96% |
Earnings Yield | -10.92% |
FCF Yield | -9.40% |
Analyst Forecast
The average price target for CADL is $11.00, which is -4.35% lower than the current price. The consensus rating is "Strong Buy".
Price Target | $11.00 |
Price Target Difference | -4.35% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |